South Korea Unveils Record $597 Billion 2027 Budget to Boost AI and Chips 
Trump Says ExxonMobil Among Oil Majors Planning Venezuela Return 
GM Canada Workers Approve C$1.1 Billion Investment Deal 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Apple’s Phil Schiller Steps Back as Leadership Shake-Up Accelerates 
CIA-Linked Investor Helped Quantum Systems Expand in US 
US Tech Giants’ AI Bond Boom Raises Euro Zone Borrowing Risks 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Shein Shares Slide 9% in Hong Kong IPO Debut 
CATL Shares Fall as Hungary Plant Faces Safety Halt 
Star Entertainment Shares Fall After A$307 Million FY2026 Loss 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Aon Nears $17 Billion Deal to Buy USI Insurance From KKR 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Amazon Shares Fall as FTC Plans Ad Pricing Lawsuit 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Add as a preferred source on Google
MENLO PARK, Calif., March 21, 2018 -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual Needham Healthcare Conference in New York at 4:00 p.m. Eastern Time on Tuesday, March 27, 2018.
A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://wsw.com/webcast/needham86/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
[email protected]
[email protected]
